Rassy EE - Search Results

1

Acquired factor inhibitor in a patient with monoclonal gammopathy of undetermined significance responding to rituximab.

Rassy EE, Tabchi S, Haddad FG, Chebib R, Assi T, Kourie HR, Nasr F. Rassy EE, et al. Blood Coagul Fibrinolysis. 2016 Oct;27(7):822-824. doi: 10.1097/MBC.0000000000000472. Blood Coagul Fibrinolysis. 2016. PMID: 26626040

2

Is there a role for maintenance therapy after platinum chemotherapy in bladder cancer in the era of immune therapy?

Rassy E, Assi T, Kattan J. Rassy E, et al. Future Oncol. 2019 Dec;15(34):3877-3879. doi: 10.2217/fon-2019-0542. Epub 2019 Nov 15. Future Oncol. 2019. PMID: 31729240 No abstract available.

3

Characteristics of Incident Testicular Cancer in Lebanon - 1990-2015 Single Institutional Experience.

Assi T, Nasr F, Rassy EE, Ibrahim T, Jabbour H, Chahine G. Assi T, et al. Among authors: rassy ee. Asian Pac J Cancer Prev. 2016;17(4):1899-902. doi: 10.7314/apjcp.2016.17.4.1899. Asian Pac J Cancer Prev. 2016. PMID: 27221873 Free article. Clinical Trial.

4

Personalized treatment of prostate cancer: better knowledge of the patient, the disease and the medicine.

Aoun F, Rassy EE, Assi T, Kattan J. Aoun F, et al. Among authors: rassy ee. Future Oncol. 2016 Oct;12(20):2359-61. doi: 10.2217/fon-2016-0292. Epub 2016 Jul 18. Future Oncol. 2016. PMID: 27424848 No abstract available.

5

Diffuse edema suggestive of cytokine release syndrome in a metastatic lung carcinoma patient treated with pembrolizumab.

Rassy EE, Assi T, Rizkallah J, Kattan J. Rassy EE, et al. Immunotherapy. 2017 Mar;9(4):309-311. doi: 10.2217/imt-2016-0134. Immunotherapy. 2017. PMID: 28303768

6

PDL-1/PD1 inhibitors: antibody or antinobody?

Aoun F, Rassy EE, Assi T, Kattan J. Aoun F, et al. Among authors: rassy ee. Future Oncol. 2017 Aug;13(19):1669-1671. doi: 10.2217/fon-2017-0215. Epub 2017 Aug 23. Future Oncol. 2017. PMID: 28831825 No abstract available.

7

Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?

Rassy E, Assi T, Pavlidis N. Rassy E, et al. Br J Cancer. 2020 Apr;122(8):1124-1132. doi: 10.1038/s41416-019-0723-z. Epub 2020 Feb 11. Br J Cancer. 2020. PMID: 32042068 Free PMC article. Review.

8

Immune checkpoint inhibitors renal side effects and management.

Rassy EE, Kourie HR, Rizkallah J, Karak FE, Hanna C, Chelala DN, Ghosn M. Rassy EE, et al. Immunotherapy. 2016 Dec;8(12):1417-1425. doi: 10.2217/imt-2016-0099. Immunotherapy. 2016. PMID: 28000536 Review.

9

Advances in urothelial bladder cancer immunotherapy, dawn of a new age of treatment.

Aoun F, Rassy EE, Assi T, Albisinni S, Katan J. Aoun F, et al. Among authors: rassy ee. Immunotherapy. 2017 Mar;9(5):451-460. doi: 10.2217/imt-2017-0007. Immunotherapy. 2017. PMID: 28357911 Review.

10

Management of stage III non-small cell lung cancer.

Tabchi S, Kassouf E, Rassy EE, Kourie HR, Martin J, Campeau MP, Tehfe M, Blais N. Tabchi S, et al. Among authors: rassy ee. Semin Oncol. 2017 Jun;44(3):163-177. doi: 10.1053/j.seminoncol.2017.10.009. Epub 2017 Oct 18. Semin Oncol. 2017. PMID: 29248128 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters